These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10242200)

  • 21. Evidence-based decision making in managed care pharmacy.
    Penna P
    Manag Care Interface; 2002 May; 15(5):43-4. PubMed ID: 12024870
    [No Abstract]   [Full Text] [Related]  

  • 22. Cephalosporin selection: view from a beleaguered P & T committee member.
    Talley JH
    Hosp Formul; 1986 Jan; 21(1):76-8, 83-4. PubMed ID: 10275082
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multidisciplinary education ensures successful formulary conversion.
    Barfield PS; Amerson AB
    Hosp Formul; 1991 Nov; 26 Suppl D():28-9. PubMed ID: 10136563
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Developing an effective P & T Committee, Part 2.
    Abramowitz PW; Godwin HN; Latiolais CJ; McDougal TR; Miller WA; Ravin RL
    Hosp Formul; 1985 Oct; 20(10):1071-2, 1078-81, 1086 passim. PubMed ID: 10273830
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Editors' roundtable: Current formulas for P & T Committee success (Part 1).
    Lipman AG; Neu HC; Singh BN; Weintraub M
    Hosp Formul; 1987 Mar; 22(3):288-98. PubMed ID: 10312015
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The truth about hospital formularies: survey shows many myths still exist 15 years later.
    Pa Nurse; 2005 Jun; 60(3):30, 33. PubMed ID: 16032986
    [No Abstract]   [Full Text] [Related]  

  • 27. Formulary management to reduce cost: P & T committee strategies.
    Roberts MJ; Summerfield MR
    Hosp Formul; 1986 Apr; 21(4):481-3, 488-92. PubMed ID: 10276289
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effective decision-making in a changing healthcare environment: a P & T Committee interview.
    Zoloth A; Yon JL; Woolf R
    Hosp Formul; 1989 Feb; 24(2):85-7, 90, 93 passim. PubMed ID: 10291815
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Guidelines on the operation of the pharmacy and therapeutics committee and formulary.
    Linkewich JA; Prevoznik SJ
    Hosp Pharm; 1979 Jan; 14(1):7-10, 13, 16-9 passim. PubMed ID: 10240149
    [No Abstract]   [Full Text] [Related]  

  • 30. A multicenter model for examining in vitro susceptibilities of bacteria to antibiotics.
    Day D; Mangi R; Jenkins S; Ivey MF
    Hosp Formul; 1989 Sep; 24(9):513-6, 519-20, 523. PubMed ID: 10294666
    [TBL] [Abstract][Full Text] [Related]  

  • 31. How to crack the $2 billion hospital market for pharmaceuticals.
    Zellmer WA
    Med Mark Media; 1981 May; 16(5):16, 24. PubMed ID: 10251527
    [No Abstract]   [Full Text] [Related]  

  • 32. Prospective reimbursement and DRGs: implications for formulary management.
    Enright SM
    Hosp Formul; 1983 Oct; 18(10):989-90, 999-1000. PubMed ID: 10310246
    [No Abstract]   [Full Text] [Related]  

  • 33. Understanding, creating, and working with formulary systems.
    Quinn CE; Barisano A
    Am J Manag Care; 1999 Oct; 5(10):1311-7; quiz 1318-9. PubMed ID: 10622996
    [No Abstract]   [Full Text] [Related]  

  • 34. Editors' roundtable: current formulas for P & T Committee success. (Part 2).
    Lipman AG; Neu HC; Singh BN; Weintraub M
    Hosp Formul; 1987 Apr; 22(4):373-82. PubMed ID: 10281367
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Formulary management in an integrated health care system.
    Beis SJ; Anandan JV
    Pharm Pract Manag Q; 1999 Jan; 18(4):43-9. PubMed ID: 10339067
    [No Abstract]   [Full Text] [Related]  

  • 36. Drug management. Making introductions.
    Russell E; Bool P
    Health Serv J; 1999 Feb; 109(5643):28-9. PubMed ID: 10387432
    [No Abstract]   [Full Text] [Related]  

  • 37. Predetermined standards in drug use control.
    Lipman AG
    Hosp Formul; 1979 Sep; 14(9):864. PubMed ID: 10243911
    [No Abstract]   [Full Text] [Related]  

  • 38. P & T Committee interview: strategies to ensure an effective formulary system.
    Riff L; Hutchinson R
    Hosp Formul; 1988 Nov; 23(11):901-4, 907-8. PubMed ID: 10290754
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Issues in formulary management: therapeutic interchange. Establishing guidelines: roundtable discussion, Part 1.
    Mahoney C; Cichon M; Cromer M; DeGiulio H; Renshaw B; Rodriguez FA; Wert D
    Hosp Formul; 1992 Oct; 27 Suppl 2():4-8. PubMed ID: 10122036
    [No Abstract]   [Full Text] [Related]  

  • 40. The role of the microbiology laboratory in guiding formulary decisions.
    Stratton CW
    Hosp Formul; 1988 Aug; 23(8):654-7. PubMed ID: 10312591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.